跳至主要内容
临床试验/NCT02182934
NCT02182934已完成2 期

Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Recreational Sports People: a Double-blind, Placebo Controlled Pilot Study

Boehringer Ingelheim0 个研究点目标入组 26 人开始时间: 1999年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
26
主要终点
Baseline-adjusted half-time hemoglobin re-oxygenation

研究概览

简要总结

To assess the efficacy of Ginsana in improving hemoglobin re-oxygenation in healthy, recreational sports people and to assess the safety of the product.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female volunteers between 18 and 40 years old
  • Females must test negative for pregnancy
  • Recreational athletes according to the american college of sports medicine (ACSM) definition
  • Familiar with the cycle ergometer exercise methodology
  • Written inform consent according to good clinical practice (GCP) and local regulations

排除标准

  • Pre treatment and/or concomitant treatment with any drug that any drug that may influence the trial symptomatology
  • Alcohol and drug abuse as stated in the clinical trial manual
  • Known hypertension
  • Known hypercholesterolemia (moderate/severe)
  • Female volunteers taking oral or injectable contraceptives
  • Female volunteers of child bearing potential not using adequate means of birth control, other than contraceptive pills [intrauterine devices (IUDs)]
  • Pregnancy and/or lactation
  • Liver and/or renal and/or vascular disease
  • Relevant allergy or known hypersensitivity to the investigational drug or its excipients
  • Participation in another clinical trial within the last 4 weeks before the date of inclusion or concurrent participation in another clinical trial

研究组 & 干预措施

Ginsana

Experimental

干预措施: Ginsana (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Baseline-adjusted half-time hemoglobin re-oxygenation

时间窗: day 84

次要结局

  • Change from baseline in thiobarbituric acid (TBARS)(Baseline, up to day 84)
  • Change from baseline in glutathione superdismutase/glutathione superdismutase oxidised (GSG/GSSG) ratio(Baseline, up to day 84)
  • Change from baseline in respiratory threshold(Baseline, up to day 84)
  • Baseline-adjusted half-time hemoglobin re-oxygenation(day 21, 42 and 63)
  • maximum endurance time(day 21, day 42, day 63 and day 84)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验